News

Discover PROVOQUE™: The Future of Regenerative Skincare

Discover PROVOQUE™: The Future of Regenerative Skincare

Introducing PROVOQUE™: A New Era in Skincare

LevEllis, Inc., a notable name in the skincare industry, has unveiled its latest innovation: PROVOQUE™, a revolutionary regenerative skincare serum. The company, founded by prominent surgeon and molecular biologist Dr. Laura Ellis, boasts a talented scientific advisory board guiding its mission to deliver effective skincare solutions. PROVOQUE™ utilizes cutting-edge biotechnology, setting a new benchmark in the realm of skincare products.

What Makes PROVOQUE™ Unique?

The hallmark of PROVOQUE™ is its proprietary secretome technology, which is formulated from human skin progenitor cells. Unlike traditional products that often rely solely on isolated growth factors or exosomes, PROVOQUE™ encompasses a complete skin-specific secretome. This innovative blend includes a rich matrix of peptides, growth factors, cytokines, microRNA, exosomes, and regenerative molecules that work synergistically to restore and rejuvenate the skin.

A Personal Touch from Experts

Dr. Laura Ellis expressed enthusiasm over the launch, stating, "We are thrilled to introduce a next-generation advancement in regenerative aesthetics. This serum not only revitalizes skin but also offers potential benefits for hair revitalization." PROVOQUE™ stands firmly at the intersection of scientific evidence, innovation, and elegance, bringing a unique approach to skincare.

High Standards for Health and Safety

This remarkable serum is free from fragrances, detergents, oils, and organic solvents. The formulation is meticulously designed to maintain the biological integrity of its active ingredients, mitigating the risk of inflammatory cellular debris. Through a scientifically validated approach, PROVOQUE™ exemplifies the pioneering spirit of regenerative aesthetics.

The Foundations of PROVOQUE™

Prominent scientist Hans Keirstead, PhD, inventor of PROVOQUE™ technology, highlighted the significance of skin-specific cellular science in the serum's formulation. This formulation helps generate a complete skin secretome, which is critical for achieving radiant, healthier skin. Dr. Keirstead notes, "Clinical studies have revealed improvements in skin appearance and texture in as little as 14 days," showcasing the efficacy of this innovative product.

Supporting Expertise

LevEllis, Inc. is complemented by a distinguished scientific advisory board that includes experts across various domains, such as oculofacial surgery, dermatology, biotechnology, and regenerative medicine. Their combined expertise ensures LevEllis, Inc. stays at the forefront of skincare innovation, continually enhancing its product offerings.

About LevEllis, Inc.

Co-founded by Dr. Laura Ellis, LevEllis, Inc. is dedicated to advancing skincare through science-driven solutions. The company includes a team of seasoned professionals and commercialization experts who have successfully introduced major skincare products to the market. With its headquarters in Asheville, North Carolina, LevEllis, Inc. has entered into a significant licensing agreement with AIVITA Biomedical, granting it exclusive rights to market and distribute several proprietary formulations under the PROVOQUE™ brand.

AIVITA Biomedical, Inc. Insights

AIVITA Biomedical, Inc. is known for its commitment to stem cell applications in biotechnology. Their unique complex derived from young skin stem cells plays a vital role in enhancing skincare products and offers compelling insights into the science of beauty.

Frequently Asked Questions

What is PROVOQUE™?

PROVOQUE™ is a regenerative skincare serum that utilizes advanced biotechnology to rejuvenate the skin with a unique secretome technology derived from human skin cells.

How does PROVOQUE™ differ from traditional skincare products?

Unlike traditional products focusing on isolated growth factors, PROVOQUE™ blends a complete skin-specific secretome for enhanced results.

What are the key ingredients in PROVOQUE™?

PROVOQUE™ contains peptides, growth factors, cytokines, microRNA, exosomes, and regenerative molecules to restore and renew the skin.

Is PROVOQUE™ suitable for all skin types?

Yes, PROVOQUE™ is formulated without harmful ingredients and is designed to be gentle on the skin while delivering effective results.

How long does it take to see results from using PROVOQUE™?

Many users report visible improvements in skin texture and appearance within as little as 14 days of using PROVOQUE™.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

GoDaddy Faces Class Action: Investor Stakes High

Updated Category News Views 3

GoDaddy's Legal Turbulence: What's at Stake? Sometimes riding the stock wave can hit unexpected snags, and that's what's up with GoDaddy right now. They're stuck in the middle of a securities deception storm that's sending shivers down the spine of many an investor. The Class Action Lawsuit's Core Here's what you need to know: GoDaddy, with its ticker NYSE:GDDY, is...

Continue Reading
ASU Teams Up for National Manufacturing Workforce Push

Updated Category News Views 2

ASU's Role in Reviving American Manufacturing The Foundry School is a big hit for Arizona State University (ASU) as it joins hands with seven other top-tier universities under the U.S. Departments of State and Labor's initiative. This project is all about sculpting the future players of American manufacturing. In a scene highlighted by the Vice President and girded by...

Continue Reading
Actinium Pharma Unveils Plans at Key Investor Conference

Updated Category News Views 2

Actinium Pharmaceuticals Steps into the Spotlight Alright, folks, here we have Actinium Pharmaceuticals, Inc. gearing up to make some noise at the H.C. Wainwright 28th Annual Global Investment Conference. This isn't just any roadshow—it's a chance to showcase the kind of pioneering work they're doing in targeted radiotherapies. With Sandesh Seth, the Chairman, taking...

Continue Reading
XCOTTON Shines at IFA 2026: The New Horizon of Commerce

Updated Category News Views 1

Shifting Gears at the Checkout Counter Let's face it, we've all been there: you click, you pay, and then you wait. But what happens next is where brands often drop the ball. Sure, e-commerce has been all about getting us to trust the 'buy' button. That's where folks like XCOTTON are stepping up to the plate, giving us something else to consider. They were loud and clear...

Continue Reading
Raiders' Telenovela Hype Ignites Passion in Mexico

Updated Category News Views 1

Raider Nation's Heart Beats in Mexico Hell, you ever see a football game that feels like a soap opera? You bet your boots that's exactly what the Raiders are cooking down in Mexico City. We're not talking about just any ol' season opener; it's the curtain call of Corazón de Plata y Negro. This ain't your average fanfare—it's a spectacle teeming with raw, unfiltered...

Continue Reading
CHiQ Secures AI Award, Elevates Smart Home Living

Updated Category News Views 2

CHiQ's Big Win in the AI Game In a world where technology rarely stops spinning, CHiQ has carved its own commendable niche. Snagging the AI Home Ecosystem Brand Award at IFA 2026 in Berlin, the brand's knack for pioneering AI tech isn't just a footnote—it's the whole story. The award—enough to make your competitors green with envy—highlights how far they've come in...

Continue Reading
Midea Unveils SMART MASTER at IFA 2026: AI in Action

Updated Category News Views 2

Introduction: Midea Takes the Stage at IFA 2026 Ah, the glitz of a tech expo. This time around, Midea's making waves at IFA 2026. Their SMART MASTER system could be another notch in their belt if they pull off this seamless AI integration they keep yapping about. It's all about creating a home ecosystem that feels like it's actually got a brain—or so they say. Let's dig...

Continue Reading
Dreame's High-Tech Kitchen Innovations Unveiled at IFA 2026

Updated Category News Views 3

The Gadgets Turning Heads at IFA 2026 Cooking's gone high-tech, and it's about time. At the IFA 2026 in Berlin, Dreame Technology rolled out some primo small kitchen appliances that might just leave the old-school gear collecting dust. We're talking slick machines across six major categories: air fryers, coffee gizmos, mixers, blenders, toasters, and treat makers. Forget...

Continue Reading
Local Climate Resilience Gains Urgency in the Southwest

Updated Category News Views 1

Local Impact Means Taking Climate Change Personally If you haven't felt it yet, you will. Climate change isn't just a global headline anymore—it's a daily reality that’s reshaping life where you stand. David W. DuBois, New Mexico's top climatologist, is sounding the alarm this time on the new Net Zero Speaks episode, saying it's on us to use local climate knowledge to...

Continue Reading
BMO Sheds U.S. Branches, Eyes Strategic Growth

Updated Category News Views 1

Why BMO is Slimming Down in the States You know, when a heavyweight like BMO Financial Group starts shedding branches left and right, you gotta ask yourself what the grand plan is. In a move that looks more like a strategic dance than an abrupt U-turn, BMO's gotten rid of 138 U.S. branches, handing them over to First-Citizens Bank. We're talking outlets scattered from...

Continue Reading

Top 5 Most Recently Viewed Articles

Rover's Insightful Report on Pet Parenthood Cost Trends

Updated Category News Views 209

Understanding the True Cost of Pet Parenthood In their sixth annual report, Rover, a leading online marketplace for pet care, dives deep into the financial aspects of owning pets, highlighting significant trends among pet parents in Canada. This insightful report reveals how pet owners are adapting to a rapidly changing environment, particularly in light of new tariffs...

Continue Reading
Blink Charging Unveils Insights on EV Trends in Live Chat

Updated Category News Views 81

What to Expect from Blink’s Upcoming EV Conversation On September 12 at 10 AM E.T., Brendan Jones and Michael Battaglia will sit down for a live fireside chat—the first such discussion since Blink announced leadership changes planned for 2025. It’s a timely moment to hear directly from the team about how the electric vehicle (EV) landscape is shifting and where...

Continue Reading
MaxLinear's Innovative AI Framework Enhances Wi-Fi for Users

Updated Category News Views 167

MaxLinear Reveals New MaxAI Framework for Enhanced Wi-Fi MaxLinear, Inc. (Nasdaq: MXL), a leader in broadband access technology, has unveiled its revolutionary MaxAI framework. Designed to enhance user experiences and reduce operational costs for Multiple System Operators (MSOs), this native machine learning (ML) technology promises to address the modern challenges faced...

Continue Reading
Breakthrough Publication Highlights Phase 1 Findings of Rhenium-186 Re in Glioblastoma Treatment

Updated Category News Views 138

Exciting Developments in Glioblastoma Treatment Recent advances in the treatment of glioblastoma have emerged, particularly with the promising findings highlighted in a peer-reviewed publication featuring Rhenium-186 Obisbemeda. This innovative approach shows valuable potential for enhancing treatment outcomes for patients suffering from this aggressive form of brain...

Continue Reading
Peter Schiff Warns of Impending Bitcoin and MSTR Collapse

Updated Category News Views 146

Peter Schiff's Bold Predictions for Bitcoin and MSTR Peter Schiff, a prominent financial commentator, has once again made headlines in the cryptocurrency world with his insightful analysis of Bitcoin. His recent statements on social media have raised eyebrows, particularly regarding the future of both Bitcoin and MicroStrategy (NASDAQ: MSTR), a key player in the crypto...

Continue Reading